Rift valley fever prevention: Difference between revisions
Jump to navigation
Jump to search
Aakash Hans (talk | contribs) No edit summary |
Aakash Hans (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}} {{AAH}} | {{CMG}}{{AE}} {{AAH}} | ||
==Overview== | |||
Prevention of [[Rift valley fever]] is key for African nations because of the deep socio-economic impact the disease has in these areas. The loss of livestock and subsequent [[Infection|infections]] in humans catering to these animals has reverberating affects for that areas economies. The mainstay of prevention is to avoid exposure to animals exhibiting symptoms of infection and to reduce mosquito breeding around livestock and farms. | |||
==Prevention== | ==Prevention== | ||
===Primary Prevention=== | ===Primary Prevention=== | ||
| Line 9: | Line 11: | ||
*Effective [[Mosquito|mosquito]] control is pertinent in reducing transmission to humans. | *Effective [[Mosquito|mosquito]] control is pertinent in reducing transmission to humans. | ||
*Many [[Vaccine|vaccines]] have been developed over the course of history, with the major challenge being, formulating a one-shot vaccine for livestock. Few vaccines are undergoing testing to gain approval for use in animals. <ref>Njenga MK, Njagi L, Thumbi SM, et al. Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock. PLoS neglected tropical diseases. 2015 Mar;9(3):e0003550.</ref> | *Many [[Vaccine|vaccines]] have been developed over the course of history, with the major challenge being, formulating a one-shot vaccine for livestock. Few vaccines are undergoing testing to gain approval for use in animals. <ref>Njenga MK, Njagi L, Thumbi SM, et al. Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock. PLoS neglected tropical diseases. 2015 Mar;9(3):e0003550.</ref> | ||
===Secondary prevention=== | ===Secondary prevention=== | ||
There are no established measures for secondary prevention of this disease. | There are no established measures for secondary prevention of this disease. | ||
==References== | ==References== | ||
Latest revision as of 16:17, 17 July 2021
|
Rift valley fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rift valley fever prevention On the Web |
|
American Roentgen Ray Society Images of Rift valley fever prevention |
|
Risk calculators and risk factors for Rift valley fever prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aakash Hans, MD[2]
Overview
Prevention of Rift valley fever is key for African nations because of the deep socio-economic impact the disease has in these areas. The loss of livestock and subsequent infections in humans catering to these animals has reverberating affects for that areas economies. The mainstay of prevention is to avoid exposure to animals exhibiting symptoms of infection and to reduce mosquito breeding around livestock and farms.
Prevention
Primary Prevention
- Avoiding exposure to infected or unwell livestock.
- Separating and isolating animals with symptoms from the rest of the herd will help in curtailing the spread amongst the animals, which in turn will decrease the risk of transmission of the virus from animals to humans.
- Effective mosquito control is pertinent in reducing transmission to humans.
- Many vaccines have been developed over the course of history, with the major challenge being, formulating a one-shot vaccine for livestock. Few vaccines are undergoing testing to gain approval for use in animals. [1]
Secondary prevention
There are no established measures for secondary prevention of this disease.
References
- ↑ Njenga MK, Njagi L, Thumbi SM, et al. Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock. PLoS neglected tropical diseases. 2015 Mar;9(3):e0003550.